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Figure 1. Carriage rate of the allele 2 in the healthy control 
population cODlpared with patients with patchy alopecia areata, 
alopecia totalis, and alopecia universalis_ The chi-squared p value 
between the controls and the alopecia totalis group is 0_049 with an odds 
ratio of 2.87 with 95% confidence limits of 1.04 to 8.00. The p value 
between the controls and the alopecia universalis group is 0.005 and the 
odds ratio is 5.04 with 95% confidence limits of 1.60 to 15.7. Individuals in 
patient groups and the healthy population were unrelated, white Caucasians 
matched for age. 
kine inhibitors (IL-1ra). A -relative deficiency of dIe IL-lra could 
result in dIe perpetuation and increased severity of chronic inflam­
matory skin diseases_ 
We have demonstrated that allele 2 of a VNTR polymorphism 
in the interleukin-l receptor antagonist gene is significandy 
increased in patients widI alopecia totalis and alopecia univer­
salis. TillS suggests that allele 2 is not involved in the suscepti­
bility to alopecia areata but affects the severity or extent of the 
disease. 
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We have also demonstrated an association between allele 2 of 
this IL-1ra polymorphism and the severity of other inflamma­
tory diseases of epithelial tissues, including systenlic lupus 
erythematosus, lichen sclerosis, and inflammatory bowel disease 
[3-5]_ 
We have tested several other polymorphisms on chromosome 2 
and have shown that the strongest association widI alopecia areata 
is widI dIe 11.-1 receptor antagonist gene locus_ We are currendy 
investigating the VNTR polymorphism in intron 2 of dIe IL-lra 
gene to determine if it is associated with a specific production 
phenotype for either the secreted or intracellular form of the 
interleukin-1 receptor antagonist. It is probable that this polymor­
phism is a marker for a functional polymorphism elsewhere in the 
IL-1rn gene or a nearby gene . 
We report an association of an immunoregulatory gene with the 
clinical severity of alopecia areata. Our observation that the same 
allele of dris polymorphism is associated widI severity in several 
other inflammatory diseases suggests that dIe 11.-1m gene is a 
general modifying factor in chronic inflammatory diseases of epi­
dIelial, and possibly other, tissues_ 
REFERENCES 
1. Harmon CS, Nevins TD: IL-la inhibits human hair follicle growth and hair fiber 
production in whole-organ cultures. L)'mpiwkillc Cl'toki'Je Res 12:197-203, 
1993 
2. Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkasserer A, 
Duff GW: Po1ymorphlsm in human IL-l receptor antagonist gene intron 2 is 
caused by variable numbers of an 86-bp tandem repeat. Hum Genetics 
91 :403-404, 1993 
3. Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff" GW: Interleu­
kin-I receptor antagonist gene polymorphism as a disease severity factor in 
system lupus erythematosus. A,thritis Rheum 37:1380-1385, 1994 
4. Clay F, Cork MJ, Tarlow JK, Blakemore AIF, Harrington cr, Lewis FM, Duff" 
GW: Interleukin 1 receptor antagonist gene polymorphism association with 
lichen sclerosis. Hum Genet 94:407-410, 1994 
5. Mansfield JC, Holden H, Tarlow JK, di Giovine FS, McDowell TL, Wilson AG, 
Holdsworth CD, Duff GW: Novel genetic association between ulcerative 
colitis and the anti.-inBammatory cytokine interleukin-l receptor antagonist. 
Gastroenterology 106:637-642, 1994 
C3H/HeJ Mouse Model for Alopecia Areata 
John P. Sundberg, * Dawnalyn Boggess, * Xavier Montagutelli, * t Margaret E. Hogan. * and Lloyd E. King, Jr.:!: 
"'The Jackson Laboratory, Bar Harbor, Maine, U.S.A.; tThe Institut Pasteur, Paris, France; and tVanderbilt University and Bureau of 
Veterans Affairs Medical Center, Nashville, Tennessee, U.S.A. 
H uman alopecia areata is a relatively common disease characterized by alopecia of acute onset that is focal, diffuse, or combinations of the two_ Microscopically, this non-scarring human alope­cia consists of dystrophic anagen or telogen hair 
follicles accompanied by a mononuclear cell infiltrate in and 
around hair follicles [1,2]. Comparable diseases have been 
sporadically reported in Dachshund and Miniature Poodle dogs 
[3,4], Siamese cats [3], Palomino and Appaloosa horses [3], and 
some non-human primate species [3]. A spontaneous mutation 
Reprint requests to: Dr. John P. Sundberg, The Jackson Laboratory, 600 
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occurred in the rat that has been developed as an aninIal model 
for alopecia areata_ The nmtant stock has been designated the 
Dun�ee Experimental Bald Rat [5]_ 
A large number of spontaneous and induced mutations widI 
alopecia as a major part of their phenotype are described and 
most are available through national repositories, such as the one 
at The Jackson Laboratory. Although initial review of the literature 
and case materials failed to identify a mouse model for alopecia areata, 
in 1991 a single C3H/HeJ female mouse from a large production 
colony was diagnosed with what appeared to be alopecia areata. 
Subsequent investigations have confirmed that alopecia areata occurs 
spontaneously as an aging disease of very low frequency (0_25% of 
female mice, 0_035% of male mice 5-6 mondIs of age) in dris strain_ 
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The disease occurs most commonly in female mice 6 months of age 
and older and in male mice that are 12 months of age and more [1]. 
We established a colony, starting with affected breeders , where the 
incidence is now 6.3% in male and 14.4% in female mice, by 18 
months of age. Crosses were set up to identifY genes involved in the 
disease that seems to be controlled by at least one dominant or 
semi-dominant gene with reduced penetrance. 
Affected C3H/Hej mice can be first recognized by a diffuse 
ventral alopecia that starts initially on the medial aspects of the 
proximal portion of the rear legs [1]. Alopecia of the dorsal 
truncal skin develops as circular foci that can be solitary or 
multifocal. These foci wax and wane. Approximately 17% 
progress to generalized alopecia [1]. Therefore, mice can present 
a variety of lesions ranging from focal alopecia, large areas of 
alopecia that appear to involve hair cycle waves, a generalized 
thinning of the hair coat, to diffuse alopecia [2]. 
Microscopically, all hair follicle types [2] are affected. Only 
follicles in anagen are found with a severe mixed inflammatory 
cell (predominantly lymphocytic) infiltrate in and around the 
follicles. The isthmus and to a lesser degree the bulb regions are 
primarily illvolved. Intrafollicular migration of lymphocytes is 
associated with disruption of the follicular sheaths, focal necrosis 
with separation at the junction of the dermal papilla and matrix 
cells, and structural changes in the hair shaft resulting in focal 
destruction with loss of pigment [1,2]. Scanning electron micro­
scopic studies of hairs have revealed focal degenerative changes 
illcludillg longitudinal fissures, loss of cuticle, flattening, and 
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breakage with splinterillg of the hair shafts. The alopecia is due 
to breakillg off of hair shafts as they emerge from the skin. 
The lymphocytic infiltrate in and around hair follicles consists 
predomillantly of CD8+ lymphocytes and smaller numbers of 
CD4 + cells. These can be elimillated by intralesional steroid 
illjections resultillg ill regrowth of the hair [1]. 
C3H/Hej mice are readily available from production colonies 
at The jackson Laboratory. However, these mice rarely have 
alopecia areata at the age of shipment. Mice have to be aged and 
followed to determine which will develop the disease. 
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Fibroblast Growth Factor and the Hair Cycle of the 
Hairless Mouse 
Diana L. du eros 
Department of Cell Biology, University of Alabama at Birmingham, Birmingham, Alabama, U.S.A. 
H air follicles arise in developillg skin from complex cellular interactions illvolving molecules such as fibroblast growth factor (FGF). Immunolocaliza­tion of acidic and basic FGF (FGF-1 and FGF-2), particularly around the basement membrane zone 
(BMZ) during follicle development, demonstrates that these 
growth factors may have related functions in local tissue remodel­
ing during follicle morphogenesis, and later may serve to regulate 
cellular mitotic activity and differentiation in the follicle [1]. 
In developing skin, FGF-2 high-affinity receptors are found on 
cells of the dermal papilla as well as on the basal keratinocytes of the 
epidermis and on follicle bulb cells [2]. Heparan sulfate proteogly­
can molecules, which are components of basement membranes and 
extracellular matrix , appear to be low-affinity receptors for FGF-2; 
initial binding of FGF-2 to heparan sulfate proteoglycan molecules 
Reprint requests to: Dr. D.L. du Cros, University of Alabama at 
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is apparently essential for presentation of the growth factor to its 
high-affinity receptors. FGF-2, when injected into newborn mouse 
skin, affects both the initiation and development of hair follicles , 
and subsequently delays the hair cycle [3]. The mechanism of action 
of FGF-2 in these processes is unknown, and little is known about 
FGF-2 in relation to the hair cycle. Thus, tIlls study was undertaken 
to examine the role ofFGF-2 ill the hair cycle by examinir1g FGF-2 
expression in the skin and hair follicles of the hairless (hI") mutant 
mouse, particularly during the transition stages when substantial 
morphologic changes are occurring. 
The hairless mouse initially develops a full hair coat but, between 
the ages of 10-14 d, begins to lose hair on the face and legs. This 
continues until the whole head is bare. Shedding proceeds in a 
cephalo-caudal direction until the animal is completely naked by 
about 21 d of age [4]. There is little subsequent regeneration of the 
hair. The hair loss and lack of regrowth appears to be related to 
several events taking place during the catagen phase of the hair 
cycle. Incomplete formation of the club-hair at catagen and exces­
sive widening of the pilary canal result in premature sheddillg of the 
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